Evidence map›Paper›PMID 32943730›Full record

ReviewOncogene2020

Core transcriptional regulatory circuitries in cancer.

Ye Chen, Liang Xu, Ruby Yu-Tong Lin, Markus Müschen, H Phillip Koeffler

Abstract readReview
In one paragraph

Review in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Lineage-Selective Dependencies in Pediatric Cancers.Cold Spring Harbor perspectives in medicine · 2025
    Review
  20. The role of super-enhancer-driven lncRNAs in cancer.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ye ChenCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csicye@nus.edu.sg.ORCID http://orcid.org/0000-0003-0357-1434
Liang XuCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csixl@nus.edu.sg.ORCID http://orcid.org/0000-0002-2700-4840
Ruby Yu-Tong LinCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.ORCID http://orcid.org/0000-0003-3229-4659
Markus MüschenDepartment of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA, 91016, USA.ORCID http://orcid.org/0000-0002-6064-8613
H Phillip KoefflerCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

Funding

Metabolic gatekeepers in B-cell malignanciesR35CA197628 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2016 to 2026
$11.7M
Targeted activation of autoimmune checkpoints in B cell malignanciesR01CA157644 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2011 to 2026
$5.7M
PRE-B CELL RECEPTOR SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIAR01CA137060 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MÜSCHEN, MARKUS · 2009 to 2016
$2.7M
CD25-mediated feedback control of BCR-signaling and its oncogenic mimicsR01CA213138 · NCI · YALE UNIVERSITY · PI MÜSCHEN, MARKUS · 2017 to 2022
$1.9M
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic ApproachesR01CA200992 · NCI · CEDARS-SINAI MEDICAL CENTER · PI KOEFFLER, HAROLD PHILLIP · 2016 to 2020
$1.8M
Negative feedback signaling in tyrosine kinase-driven leukemiaR01CA172558 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MÜSCHEN, MARKUS · 2013 to 2015
$972k
Howard Hughes Medical Institute (HHMI) HHMI-55108547NCI NIH HHS R01 CA137060NCI NIH HHS R01 CA157644NCI NIH HHS R01 CA172558NCI NIH HHS R01 CA200992NCI NIH HHS R01 CA213138NCI NIH HHS R35 CA197628Wellcome Trust
6 · The paper itself

Abstract

Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type-specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics.

Indexed as

Antineoplastic AgentsCell Line, TumorCell Transformation, NeoplasticEmbryonic Stem CellsGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansNeoplasmsTranscription FactorsAntineoplastic AgentsTranscription Factors

Identifiers

PMID32943730
PMCPMC7581508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.